Pharmaceutical Commerce

Pharmaceutical Commerce is a publication aimed at biopharma executives who make key business decisions. It highlights the processes and technologies that play a role in bringing approved drugs to market. Our editorial content is designed to enhance teamwork among management professionals, ultimately aiming to lower the costs associated with commercial operations.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#2236662

United States

#852372

Health/Biotechnology and Pharmaceuticals

#718

Traffic sources

Monthly visitors

Articles

Peer Exchange: Understanding the Pharma Supply Chain (Episode 1)

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients.
Pharma Pulse 6/20/25: Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success; Innovation Requires Investment-and Sustained Investment Requires Sufficient Returns

1 week ago | pharmaceuticalcommerce.com | Don Tracy

Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial SuccessIn an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer at Novotech, emphasized the value of trust-based CRO-sponsor relationships and celebrated the company’s Citeline CRO Partnership of the Year Award for its collaboration with Tune Therapeutics as a model of strategic, patient-centered clinical trial partnership.
How Medicare Eligibility Affects Healthcare Use in Adults with Psychological Distress

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

One of several public health issues of utmost importance are mental health disorders, which are quite commonplace.
Pharma Pulse 6/19/25: Strategic Planning in the Rebate Economy; The Truth About AI Adoption Speed in Clinical Research

1 week ago | pharmaceuticalcommerce.com | Don Tracy

Strategic Planning in the Rebate Economy: What Pharma Must Do NowA recent Pharmaceutical Executive article outlines how, despite decades of evolving policy from OBRA ’90 to the Inflation Reduction Act, the US pharmaceutical system remains deeply reliant on manufacturer rebates—prompting drugmakers to shift from workaround tactics to strategic execution in order to thrive in today’s rebate-driven environment while preparing for a more transparent, reform-ready future.
Establishing Additional Transparency

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In a video interview with Pharma Commerce, LeAnn Boyd, PharmD, Liviniti’s founder and CEO, discusses the deeper, systemic issues behind rising healthcare and drug costs that are not fully addressed by the MFN (Most-Favored Nation) executive order. She acknowledges that the healthcare landscape has seen incredible advancements in therapies that significantly improve patient outcomes and well-being.
TekniPlex Healthcare Unveils New Barrier Protection Systems Plant

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

TekniPlex Healthcare, a supplier of barrier films, unit-dose containers, and more, has opened its new 200,000-square-foot facility in Madison, WI, which was made official with a ribbon-cutting ceremony last week. The new site—representing its second Madison plant—acts as the flagship location for the company’s barrier protection systems business, and will strive to further grow its protective solutions services.
The Impact of Initial Coverage Choice

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

Data show that nearly two-thirds of Medicare beneficiaries feel that their coverage completely meets their expectations.
DSCSA Compliance: The Time is Now

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

Key TakeawaysDSCSA enforcement deadlines are phasing in through 2025, with wholesalers and repackagers already required to comply as of May 27, and wholesale distributors facing an August 27 deadline—provided they show active progress on data connections. Despite past delays and exemptions, industry stakeholders report significant progress, with data connectivity between manufacturers and distributors improving markedly and success rates reaching 90%–95%.
Conference Connect: Determining the Future of Specialty Pharmacy

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

Asembia’s AXS25 Summit—held annually at both the Wynn and Encore in Las Vegas, NV—brings together thousands of pharmaceutical industry executives in hopes of continuing the conversation surrounding specialty pharmacy. Specifically, this includes not only the potential challenges in the space, but also solutions that can impact the industry’s future—one that includes rare disease patients and improving their health outcomes.
Pharma Pulse 6/18/25: The Complexities of Drug Discounting; How Clinical Operations Teams Are Adapting to Oncology Trial Challenges

1 week ago | pharmaceuticalcommerce.com | Don Tracy

The Complexities of Drug DiscountingA Pharmaceutical Executive article explores how the growing complexity and lack of transparency in drug discount programs are undermining their intended benefits, often leaving patients, healthcare providers, and manufacturers with significant financial burdens and little access to true savings.